Home Insights Pivoting Oncology Launch Plans Amid COVID-19

Pivoting Oncology Launch Plans Amid COVID-19

Less than 1 min read

The pandemic has affected how new therapies are commercially launched. This has led to many life science manufacturers having to pivot to ensure patients are able to access the medications they need. Unprecedented times have led to them seeking a fresh approach and turning to Vynamic for support in planning and executing oncology launches.

In this case study, Vynamic assists two pharmaceutical companies in forming an alliance to launch two separate oncology products. Working both externally and internally, Vynamic mapped out four key changes to ensure both launches were successful from day one.

Vynamic also demonstrates how a brand can grow its share within the market two months post-approval through a coordinated and targeted virtual customer engagement plan and digital execution.

Read the full case study here.


Other similar insights

Case Study – Creating a flexible, customised, full contact centre solution

Ashfield Engage, Vynamic and MicroMass deliver an integrated full contact centre solution.

Read more

Ashfield Engage and MicroMass collaborate to provide integrated client solution

Ashfield Engage and MicroMass Communications deliver an outstanding patient experience strategy.

Read more

Ashfield Engage acquires Nuvera to enhance Patient Solutions offering

Ashfield Engage announces the completion of the acquisition of Nuvera LLC, a US-based healthcare consulting firm.

Read more

Implementing a customer service team with speed and agility

A global medical company producing innovative skin regeneration treatments was looking for a customer service centre to support its products.

Read more

Creating dedicated customer service and medical information teams

A medical company was looking for a dedicated customer service team and nurse medical information programme to support its gene therapy treatments.

Read more

Solving Problems and Engaging Caregivers With Applied Lean Methodology

Health systems and their leaders are constantly faced with the challenge of becoming more efficient and innovative in their approach.

Read more

Ashfield Excellence Academy launches to deliver specialist pharma and healthcare training

Ashfield Excellence Academy, previously Ashfield Insight & Performance, has renamed to more clearly reflect its purpose.

Read more

Improving patient experience in Cell and Gene Therapies through a data-centric approach

Cell and gene therapies (C&GTs) continue to expand with 3,366 currently in preclinical and clinical development.

Read more

Partnering to create flexible, customised, full contact centre solution

Ashfield Engage, Vynamic and MicroMass deliver an integrated full contact centre solution

Read more